If you want to receive trading signals - like these in real time - register on the platform and buy the Pro version of LargeTrader.

Illumina Inc trading signal - ILMN

U.S. stock price signals and analysis

Good morning Traders,

With the May 25 close,  Lift-Off confirms a SHORT trading signal on the U.S. stock Illumina Inc (Ticker: ILMN) listed on NASDAQ and part of the S&P500 index.

Following the retracement of the signal, the red LIft-off band rekindled with the June 9 close, and the SP500 index on Friday closed higher driven by the big companies, while most companies posted negative performance.

The stock closed at US$200.53 per share, marking a -1.08%.

Below the chart of Illumina Inc - ILMN - with the signal detected by Lift-Off 

The company is active in the "Health Technology" industry specifically in the "Biotechnology Industry"

Profile

Illumina Inc (ILMN) is a leading life science and genomics company. Founded in 1998, the company focuses on providing innovative solutions for genetic research, clinical diagnosis and the application of genomics in various fields, including agriculture and precision medicine.

Illumina is renowned for its high-speed, high-precision DNA sequencing technology. Its sequencing systems enable scientists to analyze DNA and RNA quickly and efficiently, opening up new opportunities for understanding genetic diseases, personalized drug discovery, and advancing scientific research.

The company also offers a wide range of instruments, reagents, and software to support genomic applications, including human genetics, microbial genomics, precision agriculture, and cancer research.

With a strong customer base around the world, Illumina collaborates with research institutes, medical centers, pharmaceutical companies, and biotechnology companies to accelerate innovation in genomic science. The company is committed to the continued research and development of advanced technologies to improve understanding of the human genome and promote personalized medicine.

Illumina is recognized as a major player in the genomic revolution, working to transform medical practice and open new horizons in the diagnosis, treatment and prevention of disease.

Next earnings announcement for Q2 2023:July 31, 2023

Q1 2023 Results

EPS: Reported 0.08 / Expected 0.01 / Previous 0.14

Earnings: Reported 1.09B / Expected 1.07B / Previous 1.08B

Financial Overview: The current market capitalization of ILMN amounts to 31.704B USD. 

Accounts, including revenue, expenses, profit and loss: ILMN's total revenue for the latest quarter is 1.09B USD, up 0.37% from the previous quarter. Net income in Q1 23 is 3.00M USD.

Earnings and Revenues: ILMN's earnings for the last quarter are 0.08 USD while the estimate was 0.01 USD, which explains the change of 1341.96%. The company's revenue for the same period is 1.09B USD despite the estimated figure of 1.07B USD. Estimated profits for the next quarter are 0.03B USD, while revenues are expected to reach 1.17B USD. Also observe the annual changes over time to get a broader picture of ILMN's profit and revenue dynamics.

Source data overview and accounts: Tradingview.com

Signal board of June 11, 2023

SHORT - Illumina Inc - ILMN

Input price: $200.53 USD (and any opening price, watch for wide GAPs)

Important: 

Remind that the signal has been chosen from those detected by the Lift-Off indicator, visible in the signals area, but will NOT be communicated the management of the trade.

We recommend managing the operations as shown during the professional courses on using the platform available at this link https://it.largetrader.com/event